US OptionsDetailed Quotes

TBPH241220C17500

Watchlist

0.00
0.000.00%

15min DelayClose Nov 25 09:30 ET

0.00High0.00Low

Theravance Biopharma Stock Discussion

Moomoo AI

Feb 5 08:17

Analysts show high confidence in Theravance Biopharma's growth rate, predicting a breakeven point by 2026. The company's lack of debt, which is unusual for a loss-making pharma, reduces the risk around investing in the company.

Theravance Biopharma, Inc.'s (NASDAQ:TBPH) Shift From Loss To Profit

Moomoo AI

Jan 9 06:20

Theravance Biopharma's high P/S ratio is alarming considering its unimpressive revenue predictions. Investors seem hopeful for a business turnaround, but analysts lack confidence. The anticipated revenue growth could pressure the share price.

Investor Optimism Abounds Theravance Biopharma, Inc. (NASDAQ:TBPH) But Growth Is Lacking

Moomoo AI

Dec 21, 2023 18:34

The appointment of Jeremy Grant and the cooperation with Irenic are seen as positive steps towards strengthening Theravance's position. Irenic supports Theravance's potential to successfully complete the Phase 3 trial of ampreloxetine and deliver enhanced value to shareholders.

Press Release: Theravance Biopharma, Inc. Announces Appointment of Jeremy Grant to Board of Directors

Trytosaveabit

Nov 13, 2023 07:25

Update

$Theravance Biopharma (TBPH.US)$ Viatris And Theravance Biopharma Announce Top-Line Results From Yupelri Phase III Trial In China For The Treatment Of Chronic Obstructive Pulmonary Disease
Moomoo 24/7· 3 mins ago

Moomoo AI

Nov 12, 2023 06:46

The consensus remains at US$14.50 despite weaker earnings forecast, suggesting a belief in a minimal long-term impact to valuation. Yet, the rise in anticipated losses next year and reduced revenue predictions might raise investor concerns about Theravance Biopharma.

Bearish: Analysts Just Cut Their Theravance Biopharma, Inc. (NASDAQ:TBPH) Revenue and EPS Estimates

ClydePeternuts

May 16, 2023 03:15

Tracking Seth Klarman's Baupost Group Holdings - Q1 2023 Update

Seth Klarman’s 13F portfolio value decreased from $6.13B to $5.85B this quarter.
Baupost Group increased Alphabet and Fidelity National Information Services while dropping Meta Platforms, Micron Technology, and Amazon.com.
The portfolio continues to be heavily concentrated with the top three positions accounting for ~40% of the 13F portfolio.
New Stakes:
$Skyworks Solutions (SWKS.US)$ and $Jazz Pharmaceuticals (JAZZ.US)$
Stake Disposals:
$Meta Platforms (META.US)$
...

Unlock the trends of smart money: The Power of 13F Filings

Moomoo Breakfast US

Sep 19, 2022 07:22

Columns Today's Pre-Market Stock Movers: TTWO, AZO, BLUE, PRPL and More

Gapping up
In reaction to earnings/guidance:
• $AutoZone (AZO.US)$ +2.7%, $Jacobs Engineering (J.US)$ +0.9% (reaffirms Q4 EPS and adjusted EBITDA guidance)
Other news:
• $Purple Innovation (PRPL.US)$ +32.6% (confirms it received an unsolicited, non-binding proposal from Coliseum Capital Management to acquire all of the outstanding capital stock of Purple for $4.35 per share)
• $KnowBe4 (KNBE.US)$ +24.9% (received a non-binding proposal f...

moom lives

Sep 19, 2022 07:21

$FedEx (FDX.US)$ – FedEx remains on watch after plunging 21.4% in Friday’s trading following an earnings warning, its biggest-ever one-day decline.
$NCR Corp (NCR.US)$ – NCR slid another 1.3% in the premarket on top of a 20.3% plunge Friday after Morgan Stanley downgraded the stock to “equal-weight” from “overweight.” The Friday decline followed news that NCR would separate into two separate companies, and Morgan Stanley said any unlocking of value from that move may take a long time to play out....

Moomoo Breakfast US

Jul 14, 2022 07:35

Columns Today's pre-market stock movers: TSLA, JPM, NVAX, CAG and more

Gainers:
• $Theravance Biopharma (TBPH.US)$ +15.9% (TBPH to sell all of its units in Theravance Respiratory to RPRX for over $1.5 bln)
• $Amryt Pharma (AMYT.US)$ +11.9% (FDA grants Orphan Drug Designation to Mycapssa for the treatment of Carcinoid Syndrome)
• $Green Brick Partners (GRBK.US)$ +7.3% (to join S&P SmallCap 600)
• $TransGlobe Energy (TGA.US)$ +6.9% (Transglobe Energy to be acquired by VALLCO Energy (EGY) in stock-for-stock...

Jesus is lord

Jul 14, 2022 03:56

$Theravance Biopharma (TBPH.US)$ good news watching this as well

No comment yet